Cormark cut shares of CannTrust (TSE:TRST) from a buy rating to a market perform rating in a report issued on Tuesday morning, BayStreet.CA reports. The firm currently has C$7.00 price objective on the stock.

TRST has been the topic of a number of other reports. Eight Capital dropped their price target on CannTrust from C$25.00 to C$17.00 in a research report on Friday, March 29th. Bank of America restated a buy rating and issued a C$11.00 target price on shares of CannTrust in a research report on Friday, May 24th. Finally, Jefferies Financial Group raised their target price on Monster Beverage from $65.00 to $70.00 and gave the company a buy rating in a research report on Friday, May 3rd.

Shares of CannTrust stock opened at C$4.04 on Tuesday. The company has a debt-to-equity ratio of 8.20, a current ratio of 5.64 and a quick ratio of 1.90. The business’s 50 day moving average is C$6.73. The firm has a market cap of $667.80 million and a PE ratio of -33.39. CannTrust has a twelve month low of C$3.50 and a twelve month high of C$15.50.

About CannTrust

CannTrust Holdings Inc produces and sells medical and recreational cannabis in Canada. It sells dried cannabis and cannabis extracts to the medical patients. CannTrust Holdings Inc was incorporated in 2015 and is headquartered in Vaughan, Canada.

See Also: Systematic Risk

Receive News & Ratings for CannTrust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CannTrust and related companies with MarketBeat.com's FREE daily email newsletter.